April 8, Pfizer and Allergan Terminate $160 Billion Merger; New US Treasury Department Action at Play Pfizer and Allergan have called off their proposed $160 billion merger citing the US Depart

First Page		Document Content
Date: 2016-04-08 15:57:35 American brands Pharmacy Specialty drugs Biotechnology Allergan Plc Hospira Pfizer WuXi PharmaTech Biopharmaceutical AstraZeneca Infliximab Teva Pharmaceutical Industries		April 8, Pfizer and Allergan Terminate $160 Billion Merger; New US Treasury Department Action at Play Pfizer and Allergan have called off their proposed $160 billion merger citing the US Depart Add to Reading List Source URL: www.dcat.org Download Document from Source Website File Size: 297,81 KB Share Document on Facebook

	MODERN SLAVERY ACT STATEMENTWm Morrison Supermarkets PLC This statement is made pursuant to section 54 of the Modern Slavery Act 2015 and covers our financial year DocID: 1xV6l - View Document
	Matters Reserved for the Vodafone Group Plc Board The Board of Vodafone Group Plc (the “Company”), in carrying out its duties, must take into account the requirements of the Companies Act 2006, the Listing Rules and DocID: 1xUax - View Document
	Informa LEI: 5493006VM2LKUPSEDU20 Press Release 25 July 2018 Informa PLC Half-Year Results for Six Months to 30 June 2018 DocID: 1xTTR - View Document
	Informa LEI: 5493006VM2LKUPSEDU20 Press release 12 June 2018 Informa PLC Company Update DocID: 1xTxA - View Document
	JTC PLC MODERN ANTI-SLAVERY AND HUMAN TRAFFICKING STATEMENT FOR YEAR ENDED 31 DECEMBER 2017 DocID: 1xTnO - View Document